Hypertension in pregnancy is defined as systolic blood pressure (SBP) ≥ 140 mm Hg or diastolic blood pressure (DBP) ≥ 90 mm Hg or both on two different occasions at least 6 hours apart. Severe hypertension is SBP ≥ 160 mm Hg or DBP ≥ 110 mm Hg. Hypertension is the most common medical problem in pregnancy and one of the major causes of maternal and perinatal mortality and morbidity. Hypertensive disorders in pregnancy (HDP) are classified as (1) chronic hypertension, (2) chronic hypertension with superimposed preeclampsia, (3) preeclampsia-eclampsia, and (4) gestational hypertension. HDP contributes to increased risk of hypertension, stroke, and maternal cardiovascular disease (CVD) in later life. HDP can be considered as a failed cardiovascular stress test identifying women susceptible to CVD in later life. Further research is required to identify the mechanisms in HDP that contribute to CVD in later life so as to initiate appropriate prevention measures.
Introduction
Hypertension in pregnancy is defined as systolic blood pressure(SBP)≥140mmHgordiastolicbloodpressure(DBP) ≥90mmHgorbothontwodifferentoccasionsatleast6hours apartbutnomorethan1weekapart.AnSBPof140to159 andaDBPof90to109areconsideredasmildtomoderate hypertension. Severe hypertension is SBP ≥ 160 mm Hg or DBP≥110mmHg 1 (►Fig. 1).
Incidence and prevalence
Hypertensionisthemostcommonmedicalprobleminpregnancy. Hypertensive disorders in pregnancy (HDP) occur in 10% pregnancies. 1 They are one of the major causes of maternal and perinatal mortality and morbidity. Chronic hypertension accounts for 30% of HDP, and pregnancyinduced hypertension (PIH) occurs in 70%.
2 Chronic hypertensioncomplicatesabout1to5%ofpregnancies,gestational hypertensioncomplicatesaround5to6%,andpreeclampsia complicatesnearly3to6%pregnanciesaccordingtopopula-tion-baseddata.
3,4

Classification
Hypertensivedisordersduringpregnancyareclassifiedinto four categories 5 (►Fig. 2).
Chronic Hypertension
Chronic hypertensionisdefinedashypertensionknownprior toconception,isdetectedbefore20weeksofgestation,and usuallypersistsbeyond12weekspostpartum. Occasionally blood pressure (BP) may be normal in the first trimester withhypertensiondetectedbefore20weeks.Insuchcases, gestationalhypertensionorearlypreeclampsiamustalsobe considered.
• Etiology:Chronichypertensionisaprimaryhypertension inmajority(90-95%)ofthecases.However,secondaryand potentiallytreatablecausesareseeninafew(5-10%)that needtobeevaluatedand,iftimelytreated,couldimprove outcomeinpregnancy(►Fig. 3).
• Incidence:Chronichypertensionisseeninaround22%of womenofchildbearingagewithincreasingincidencedue toincreasingageofthemotheratthetimeofconceiving.
• Maternal and fetal outcome:Preexisting hypertensionisa riskfactorforpreeclampsia.Uncomplicatedchronichypertensioninpregnancyisassociatedwithincreasedmaternal mortalityandmorbiditythoughquitelesscomparedwith thosewhodevelopsuperimposed preeclampsia(►Fig. 4). Adverse maternal outcome is more in uncomplicated chronichypertensiveswhencomparedwithnormotensives. However,acceleratedhypertensionandorgan damageare less likely without superimposed preeclampsia. Perinatal mortalityishigherinuncomplicatedchronichypertension (relativerisk[RR]2.3)overnormotensiveandstillhigher inthosewithsuperimposedpreeclampsia.
Preconception counseling: All women diagnosed with hypertension before or in early pregnancy should be counseledregardingtherisksposedbyhypertensioninpregnancy.Theyshouldbeeducatedaboutthesignsandsymptoms of preeclampsia. Whenever secondary hypertension (►Fig. 5)issuspected,thepatientshouldbethoroughlyevaluatedtoruleofcorrectablecausesofhypertension.
Investigations
• All patients should undergo routine biochemical tests suchas:
• Serumcreatinine,uricacid,electrolytes,liverfunctional test(LFT),thyroidassessment,andurineprotein.
• Ifproteinuriaisdetected,24-hoururineproteinorurine protein-to-creatinine ratio spot urine should be done andultrasonographyofthekidneysshouldbedone. • Glucose tolerance test should be done in all as these patientsareproneforgestationaldiabetes.
• Abaselineechocardiographyforleftventricularhypertrophyandfunctionassessmentisideal.
• Case-based evaluation to rule out treatable conditions suchaspheochromocytomaandrenalarterystenosis.
Treatment and Management
The goal of treating chronic hypertension in pregnancy is to avoid its acute complications and reduce the fetal risk posedbyhypertensionitselfandthemedicationsusedforit. 
Nonpharmacologic Measures
• 
Pharmacologic Measures
PatientsofchronichypertensiononmedicationshouldmaintaintheirSBPbetween120and160mmHgandDBPbetween 80and105mmHg.
• Labetalol, nifedipine, and methyldopa are the preferred agents for initial treatment of chronic hypertension in pregnancy.
• Angiotensin-convertingenzyme(ACE)inhibitor,angiotensinreceptorblockers(ARBs),andspironolactoneagonists shouldbeavoided.
• Meta-analysis and systemic reviews have suggested a beneficialroleforlow-doseaspirinwhenstartedearlyin pregnancy(asmallbutdefinitereductioninincidenceof preeclampsiainhigh-riskpatients).
• Calcium supplementation positively reduces the incidenceofhypertension,preventspreeclampsiainhigh-risk patients,andisrecommended.
Optimaltimingfordeliveryinuncomplicatedchronichypertensioninpregnancyis38to39weeksofgestation.Normal vaginal delivery is recommended, and cesarean section is limitedtoobstetricindications.
Chronic Hypertension with Superimposed Preeclampsia
Whenorgandamageispresent,itisknownassuperimposed preeclampsiawithseverefeatures(►Fig. 6). Superimposed preeclampsia develops in 13 to 40% of patientswithchronichypertension.
Investigations
Themagnitudeofproteinuriashouldbeassessedandcompared with baseline levels. A complete blood picture with hemoglobin, platelet count, and LFT is essential. Lactic acidosis, uric acid, and creatinine assessment are required in severe preeclampsia to assess prognosis. Fetal growth and well-beingshouldbemonitoredperiodically.
Maternal and Fetal Outcome
Adverse maternal outcome in terms of abruptio placenta, postpartum hemorrhage, and accelerated hypertension is moreinsuperimposedpreeclampsia,especiallywithsevere feature.Perinatalmortalityisalsomore(RR3.6)overuncomplicatedchronichypertension.
Treatment and Management
• Treatment of patients with mild to moderate hypertension has shown to decrease the occurrence of severe hypertensionby50%butdoesnotprevent developmentof preeclampsia (Cochrane database reviews). 6-8 β-Blockers and calcium channel blockers (CCBs) appear superior to α-methyldopa in preventing preeclampsia.
8 Acute treatment of severe hypertension can be achieved by intravenous(IV)labetalolororalnifedipineor hydralazine. Oral labetalol, nifedipine, and methyldopa are the initial agentsformaintenanceofBPafteracutecontrol.
• Antepartummanagementincludescorticosteroidadministrationforfetalmaturityif<34weeksofgestation.This isprovedtoreduceperinatalmortalityandmorbidity.
• Eclampsia is seen in 0 to 2.4% cases of superimposed preeclampsia. Role of intrapartum magnesium sulphate for seizure prevention in this subset of superimposed preeclampsia has not been studied. Task force recommendation is to administer prophylactic intrapartum magnesiumsulphateforpreventionofseizureinsuperimposed preeclampsiawithseverefeatures.
Nearly 34 to 37 weeks of gestation is the ideal time for delivery. However, delivery of the fetus is recommended irrespective of the gestational age after stabilization of the mother when superimposed preeclampsia complicated by uncontrolled BP, eclampsia, pulmonary edema, abruptio placenta, disseminated intravascular coagulation (DIC), or fetusinjeopardy.
Preeclampsia-Eclampsia
Preeclampsiaisdefinedasnewonsetofhypertension detected after 20th week of gestation association with proteinuria. The revised definition according to the ACOG has defined preeclampsiaindependentofthepresenceofproteinuria.In the absence of proteinuria, preeclampsia is defined as new onsetofhypertensionwithanyoneofthefollowing:thrombocytopenia, renal insufficiency, impaired LFT, pulmonary edema,andcerebralorvisualsymptoms(►Fig. 7). PreeclampsiawithseverefeaturesisconsideredwhenBPis ≥160/110mmHgandisassociatedwith thrombocytopenia, renal insufficiency, impaired liver function, pulmonary edema,andvisualorcerebralsymptoms.
Eclampsia refers to new onset of generalized seizure (grandmalepilepsy)inpatientswithpreeclampsia.
HELLPsyndromeisconsideredasasubtypeofpreeclampsia in which pregnant women present with constellation of finding that are Hemolysis, Elevated Liver enzymes, and LowerPlateletcount.
Etiology
Preeclampsia is a syndrome characterized by widespread endothelial dysfunction and vasospasm (►Fig. 8). Altered maternal immune response to fetal/placental tissue also contributes.
Risk Factors for Preeclampsia
Preeclampsia iscommoninfirst pregnancy, extremeage of pregnancy(<18yearsand>35years),obesewomen,family history of preeclampsia (two-to fourfold), and multiple pregnancies. Chronic hypertension, especially secondary, diabetes, obesity, systemic lupus erythematosus (SLE), and migraineallincreasetheriskfordevelopmentofpreeclampsia.Preeclampsiarecursinsubsequentpregnancies,andthe historyofpreeclampsiainpreviouspregnancyincreasesthe riskforrecurrencebysevenfold.
However, preeclampsia is noted most times in healthy nulliparous women with no comorbidity. Prediction of preeclampsia based on clinical risk factors could predict preeclampsia in 37% patients with a false-positive rate of 10%. 9 Uterine artery Doppler studies and combination of biomarkers could enhance the clinical accuracy of early detectionofpreeclampsia.
Investigations
Allwomenshouldgetabaselinecompletebloodcount(CBC), serum creatinine, uric acid, LFTs, and proteinuria assessment.Plateletcounts,liverenzymes,andproteinuriashould be reassessed weekly in mild preeclampsia. In severe preeclampsiaCBC,serumcreatinine,andLFTsneedtoberepeateddaily(alternatedayifthemotherappearsstable).
Treatment and Management Mild Preeclampsia
• Saltrestriction,strictbedrest,andrestrictionofphysical activityarenotrecommended.
• Mothershouldbeeducatedtoreportsymptomsofsevere preeclampsiasuchassevereheadache,visualdisturbances,epigastricpain,andshortnessofbreath.
• Mother should be taught to monitor fetal movements daily.
• BP measurements should be done twice weekly other thanatantenatalvisits.
• PreeclampsiawithBPpersistently<160/110mmHg,antihypertensivesneednotbeadministered.
• Optimaltimingofdeliveryis37weeks.Mildpreeclampsia at or beyond 37 weeks, delivery is recommended rather thanexpectantmanagement.
• Magnesiumsulphateforpreventionofseizuresisnotroutinelyadvisedintheabsenceofmaternalsymptoms.
Severe Preeclampsia
• Severehypertensionshouldbecontrolledwithantihypertensivestopreventthecardiovascular(CV),cerebrovascularandrenalcomplications.
• Hydralazine, labetalol, and nifedipine remain the initial agentsofchoicetobeusedinseverehypertension.
• All patients should receive prophylactic magnesium sulphateforpreventionofseizures.
• Promptdeliveryisthesafestoptionforseverepreeclampsiawithorganinvolvement.Inthefewcasesinwhichthe motherisstable,optimaltimingfordeliveryis34weeks.
• Corticosteroid for fetal lung maturity should be given if<34weeksofgestation.
Eclampsia
• All patients should receive intrapartum magnesium sulphate.Ideallyitshouldbecontinuedfor24hoursafter lastseizure.
• Loading dose of 4 to 6 mg IV followed by maintenance doseof1to2mg/hforatleast24hours.
• Magnesiumsulphateshouldbecontinued intraoperatively for those undergoing cesarean section. The half-life of MgSO 4 is5hours;ifthemedicationisdiscontinuedbefore deliveryorCS,theserumlevelsdecreaseandthepatient isatriskofpostpartumseizures.
• Allwomenshouldundergodeliveryfollowingstabilization. 
HELLP Syndrome
• Promptdeliveryisadvised.
• A course of corticosteroids are beneficial in term of improvingmaternalplateletcountswithoutanyeffecton maternalandperinatalmortality.
Gestational Hypertension
Gestational hypertension is defined as sustained hypertension detected after 20th week of pregnancy in a previously normotensive woman without the evidence of proteinuria. Itusuallydisappearsby12weekspostpartum.Itisthemost commoncauseofhypertensionduringpregnancy.Incidence variesfrom6to17%innulliparouswomento2to4%inmul-tiparouswomen.Thoughatransientcondition,thesepatients shouldbecarefullymonitoredaspreeclampsiacandevelopin one-thirdofthesepatients.Gestationalhypertensionisarisk factorfordevelopmentofchronichypertensionatlaterage.
Postpartum Hypertension
Blood pressure usually dips and remains low for 48 hours afterdeliveryandthenstartstorise.Hypertensiondetected after 72 hours postpartum is known as postpartum hypertension (►Fig. 9).
Though transient in nature, it could be a harbinger of chronichypertensioninlaterlife.
Evaluation of Hypertension in Pregnancy
A proper history, clinical examination, and basic investigationsarenecessaryinallcasesofhypertensionin pregnancy. All women with hypertension in pregnancy should be educated to report symptoms of preeclampsia, which are represented in ►Fig. 10.
Guidelines for Blood Pressure Measurement in Pregnant Women
• Bloodpressureshouldberecordedateachantenatalvisit.
Itshouldbemeasuredafteraperiodofrestinaquietenvironmentinthesittingpositionwiththearmatthelevel oftheheartusinganappropriatelysizedcuff(i.e.,length 1.5timesthecircumferenceofthearm).
• Manualmeasurementwithastandardmercurysphygmomanometeristherecommended.Automateddevicesare notrecommendedinPIH.
• Supine recording and left lateral position recording could bespuriouslylowduetoinferiorvenacava(IVC)compressionbythegraviduterus.
• ThearmwithhigherBPvaluesshouldbeusedforfurther
BPmonitoring.
• RepeatBPmeasurementafteragapofatleast15minutes whenBPishigh.
• Korotkoff'sfirstandfifthsoundsaretakenassystolicand diastolic pressure, respectively, in a few patients; fourth soundisconsideredwhenthefifthsoundapproacheszero.
Cardiovascular Findings
• S 4 isabnormalinpregnancyandsuggestsleft ventricular hypertrophy due to chronic hypertension or diastolic dysfunctionduetopreeclampsia-inducedvasospasm. • S 3 isnormallyheardinpregnancy;however,S 3 gallop is abnormal.
• Carotid bruit is in favor of atherosclerosis and suggests chronichypertension.
• Diminishedpulses/unequalpulsessuggestcoarctationof theaorta. Other Systems
• Systolic bruit in the abdomen or flank suggests renal arterystenosis.
• Retinal spasm/edema and macular detachment-severe preeclampsia.
• Liver swelling and capsular stretch-pain in the right upperquadrant.
• Clonusinseeninseverepreeclampsia.Seizuresareasign ofeclampsia.
Investigations
All patients should have these routine investigations once diagnosedwithPIH:
• Completebloodpicture.
• Bloodureanitrogen(BUN),creatinineandserumelectrolytes,calcium,andmagnesium.
• Liverfunctiontests.
• Urinedipsforproteins(urineprotein-to-creatinineratio).
• Twenty-fourhoursurineforcreatinineclearanceandproteinexcretion.
• Proteinuria>300mgisconsideredabnormal.
• Creatinine clearance < 100 mL/min is abnormal and suggestiveofrenaldysfunction.
• Hemoglobin (HbA 1C ), thyroid function tests, and serum uricacidarerecommended.
• Uricacidlevels>5mgareabnormalandsuggestiveof tubulardysfunction.
• Evaluation of lipid profile, hyperaldosteronism, and hypercortisolism should be deferred till postpartum period.
• Screening for preeclampsia: Although algorithms based onriskfactors,uterineDoppler,andbiomarkershavebeen suggested, no guidelines recommend them other than screeningbyriskfactors.
• Testingforprothrombintime-internationalnormalized ratio/activated partial thromboplastin time (PT-INR/ aPTT)isrecommendedinthepresenceofthrombocytopeniaandabnormalLFT.
• Testing for DIC and hemolysis by checking levels of lactate dehydrogenase (LDH), D-dimer, fibrinogen, and haptoglobulin is recommended when coagulation defectsaredetected.
• Electrocardiogram (ECG) and 2D echocardiography are recommendedinallcasesofPIH.
• Chest X-ray, computed tomography (CT) of the brain, magneticresonanceimaging(MRI)ofthebrain,magnetic resonance angiography (MRA), and magnetic resonance venography can be done safely without fetal risk as the situationdemands.
• Close monitoring of the fetus is essential as placental hypoperfusion resulting in fetal restricted growth and intrauterine death are common. Monthly ultrasound for fetal growth and weekly biophysical profile or twice weeklynonstresstestsaresuggested.
Treatment and Management
• Acute severe hypertension: This is a medical emergency and requires immediate attention and treatment. The ACOG 10, 11 Committee on Obstetric Practice issued updated guidelines(2015and2017)regardingtheemergencytreatmentofacute-onsetseverehypertensionduringpregnancy:
• Acute severe hypertension (SBP > 160 and DBP > 110 mm Hg) diagnosed using standard devices and techniquethatispersistentfor15minutesisamedical emergency.BPshouldbereducedtosafelevelswithin 30minutestopreventmaternalstroke.Pharmacologic algorithmismentionedin►Fig. 11.
• Oral nifedipine or oral labetalol 200 mg can be given while procuring an IV access with dose repeated in 30minutesisrequired.
• Magnesiumsulfateisrecommendedforseizureprophylaxisinseverepreeclampsiaandforcontrollingseizures ineclampsia.
• Sodium nitroprusside is for extreme emergencies and fortheshortestpossibletime-cyanideandthiocyanate toxicity in the mother and fetus, aggravating cerebral edemainthemother.
• Individuals and institutions should adopt standard guidelines for managing patients with preeclampsia and be equipped to initiate prompt treatment for hypertensive emergency. Drugs and their dosages are mentionedin►Table 1.
Thereisnodifferencebetweenintheefficacyofthethreefirst agent drugs
12 intermsofcontrolofhypertension,andpreference ofoneoverotherislefttothetreatingphysiciandiscretion. [10] [11] [12] • Mild to moderate hypertension: Nonpharmacologic treatment is recommended. According to the Cochrane database, [13] [14] [15] treatment of mild-to-moderate hypertensionduringpregnancywithantihypertensive reducesthe riskofprogressiontoseverehypertensionby50%butdoes not prevent preeclampsia. Another large multinational RCT also supports this fact. β-Blockers and CCBs appear superiortoα-methyldopainpreventingpreeclampsia:
• Bedrestandsaltrestrictionarenotrecommended.
• All patients need close monitoring for detection of diseaseprogression.
Fig. 11
Pharmacologic treatment for acute severe hypertension in pregnancy.
• Reviewofsmalltrialsshowednoimprovedoutcomewith strictBPcontroltoatarget<130/80.However,in women with preexisting end-organ damage due to chronic hypertension, a lower threshold for initiating antihypertensive medication (> 139/89 mm Hg) is recommended. Inthesepatients,theaimisforalowertargetBP,thatis, <140/90mmHg. • All patients at risk for preeclampsia should receive 75mgofaspirindailyandcalciumsupplementation.
• Severe hypertension: SBP > 160 mm Hg increases the riskofintracerebralhemorrhageinthemother,whereas DBP > 110 mm Hg is associated with abruptio placenta and fetal growth restriction. Hence antihypertensive medication should be started when SBP is > 160 and/ orDBP>110mmHg.Multipletrailshavecomparedthe different antihypertensives in pregnancy, and none have proved superior to other in terms of efficacy. However, β-blockers and CCBs appear superior to methyldopa in preventionofpreeclampsia. 16 Thedifferentdrugs available foruseinseverehypertensionarementionedin►Table 2.
AccordingtoEuropeanSocietyofCardiology,recommendationsforthemanagementofhypertensioninpregnancyare:
A.Underclass1C:
1. Nonpharmacologicalmanagementforpregnantwomen withSBPof140-150mmHgorDBPof90-99mmHg. 2. In women with gestational hypertension, or preexisting hypertension superimposed by gestational hypertension, or with hypertension and subclinical organ damage or symptoms at any time during pregnancy, 
Hypertension in Pregnancy and Future Cardiovascular Risk
• Hypertensivedisordersinpregnancyareassociatedwith increased risk (sevenfold) of hypertension, stroke, and maternalcardiovasculardisease(CVD)inlaterlife.
• The risk is higher in those with history of preeclampsia, recurrent preeclampsia, preterm delivery, and fetal restriction.TheriskofCVDiscompoundedbythe presence ofobesityoroverweight.
• All women with any subtype of HDP face the brunt.
Women with gestational hypertension are at greater risk.Nodifferencebetweenpatientswhohavereceived medication or not for hypertension during pregnancy. Severityofhypertensioncorrelatedwithhypertensionin laterlife.
• These women experience chronic hypertension and cardiovascular (CV) risk almost a decade earlier than their normotensivecounterparts.
Pathophysiology
ThereisnouniformconsensusonthemechanismsthatcontributetoincreasedCVriskinHDPpatients.Infact,HDPand CVD share common risk factors such as insulin resistance, inflammation, obesity, and hypertension. 17, 18 Parity is an independentlyriskfactorforfutureCVD;theyarerelatedina J-shapedfashion,withthetwohavingthelowestrisk. 17, 19 The twohypothesesfortheincreasedCVriskincludeendothelial dysfunctionandfamilialpropensitytohypertensionandCVD.
• Thesepatientsdemonstrateanabnormalresponsetoplacenta known as ischemic placenta wherein the placenta shows shallow invasion of trophoblasts. The abnormal placenta releases antiangiogenic proteins resulting in endothelial dysfunction. Endothelial dysfunction was initially thought to reverse to prepregnancy state by 12weekspostpartum.However,studieshavedemonstratedthatthisendothelialdysfunctionpersistsandcontributestotheriskofCVDinlaterlife(►Fig. 13).Theriskis equaltothatcontributedbyobesityand/or smoking.HDP womenarefoundtohaveincreased arterialstiffness.
• A familial disposition in these patients to chronic hypertension has been suggested. It was noticed that hypertension and CV manifestation occurred even in normotensivessiblingsofHDPwomen. ScreeningforCVD:TheACOGtaskforceonhypertensionin pregnancyemphasizesonearlyidentificationofyoungwomenatriskforCVDinlaterlifethroughproperscreeningand prevention. Currently, HDP women are routinely discharged from obstetric department without a proper CV advice and follow-up despite established data about the associated increased CVD risk. Unfortunately, there are no standard guidelinesonscreeningandtreatmentforCVriskfactorsin womenwithahistoryofHDP. 20, 21 Nospecifictimeframefor screeninghasbeenstudied.
• The American Heart Association (AHA) (2014) recommends(►Fig. 14)thatwomenwithpreeclampsiashould beevaluated6monthsto1yearpostpartumtoassessand potentially treat CV risk factors, including hypertension, obesity,smoking,anddyslipidemia.
• The 2012 Dutch Society of Obstetrics and Gynecology recommendations for CV risk management after HDP (especiallypreeclampsia)are:
• Six weeks postpartum 49 years of age: All women should be educated about the increased CV risk that theywouldfaceandencouragelifestylemodificationto optimizemodifiableCVriskfactors.
• A complete CV risk profile assessment at the age of 50years.
AllwomenwhohadHDPshouldbecloselymonitoredforCVrisk factorssuchashypertension,hyperglycemia,anddyslipidemia. Lifestyleinterventionsarethecornerstoneofprevention strategies after HDP (►Fig. 15). They have the potential to decreaseCVriskby4to13%.
Conclusion
Hypertensive disorders of pregnancy are a major issue of concernforthemotherandherinfant.Pregnancywithits enormous influence on the CV physiology is like a stress testinawoman'slife.Hypertensivedisordersinpregnancy canbeconsideredasafailedCVstresstestidentifyingthe woman susceptible to CVD in later life. Pregnancy can be consideredasachanneltoidentifywomenwhoareatrisk forfutureCVD.Asclinicians,weshouldutilizethischannel to implement lifestyle modification in women to reduce their future burden of CVD. Further research is required to identify the mechanisms in pregnancy and HDP that contributetoCVDinlaterlifesoastoinitiateappropriate preventivemeasures. 
